C-MER Medical (03309) Announces Share Repurchases and Updated Issued Shares

Bulletin Express11-27

C-MER Medical Holdings Limited (stock code: 03309) announced a Next Day Disclosure Return dated 27 November 2025. According to the filing, the number of issued ordinary shares (excluding treasury shares) changed from 1,238,112,870 to 1,237,992,870, while treasury shares increased from 17,448,000 to 17,568,000 on 27 November 2025. The total number of issued shares remained at 1,255,560,870.

On 27 November 2025, 120,000 shares were repurchased on the market at prices ranging between HKD 1.72 and HKD 1.74, totaling HKD 207,600. These repurchased shares were designated as treasury shares. The repurchase was conducted under a mandate dated 19 May 2025, authorizing the issuer to repurchase up to 125,556,087 shares, equivalent to 0.0097% of the issued shares as of the mandate date.

The filing also disclosed multiple share repurchases for cancellation from 12 July 2024 to 15 May 2025 that have not yet been canceled. The report confirms that the repurchases were in accordance with applicable exchange rules and that there have been no material changes to the previously submitted Explanatory Statement. A 30-day moratorium period applies for any new issue of shares or sale of treasury shares, through 27 December 2025, following the latest repurchase transaction.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156489206?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156489206","market":"us","top_or_hot":-1,"title":"C-MER Medical (03309) Announces Share Repurchases and Updated Issued Shares","media":"Bulletin Express","content":"<p>C-MER Medical Holdings Limited (stock code: 03309) announced a Next Day Disclosure Return dated 27 November 2025. According to the filing, the number of issued ordinary shares (excluding treasury shares) changed from 1,238,112,870 to 1,237,992,870, while treasury shares increased from 17,448,000 to 17,568,000 on 27 November 2025. The total number of issued shares remained at 1,255,560,870.</p>\n<p>On 27 November 2025, 120,000 shares were repurchased on the market at prices ranging between HKD 1.72 and HKD 1.74, totaling HKD 207,600. These repurchased shares were designated as treasury shares. The repurchase was conducted under a mandate dated 19 May 2025, authorizing the issuer to repurchase up to 125,556,087 shares, equivalent to 0.0097% of the issued shares as of the mandate date.</p>\n<p>The filing also disclosed multiple share repurchases for cancellation from 12 July 2024 to 15 May 2025 that have not yet been canceled. The report confirms that the repurchases were in accordance with applicable exchange rules and that there have been no material changes to the previously submitted Explanatory Statement. A 30-day moratorium period applies for any new issue of shares or sale of treasury shares, through 27 December 2025, following the latest repurchase transaction.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical (03309) Announces Share Repurchases and Updated Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical (03309) Announces Share Repurchases and Updated Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-27 19:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER Medical Holdings Limited (stock code: 03309) announced a Next Day Disclosure Return dated 27 November 2025. According to the filing, the number of issued ordinary shares (excluding treasury shares) changed from 1,238,112,870 to 1,237,992,870, while treasury shares increased from 17,448,000 to 17,568,000 on 27 November 2025. The total number of issued shares remained at 1,255,560,870.</p>\n<p>On 27 November 2025, 120,000 shares were repurchased on the market at prices ranging between HKD 1.72 and HKD 1.74, totaling HKD 207,600. These repurchased shares were designated as treasury shares. The repurchase was conducted under a mandate dated 19 May 2025, authorizing the issuer to repurchase up to 125,556,087 shares, equivalent to 0.0097% of the issued shares as of the mandate date.</p>\n<p>The filing also disclosed multiple share repurchases for cancellation from 12 July 2024 to 15 May 2025 that have not yet been canceled. The report confirms that the repurchases were in accordance with applicable exchange rules and that there have been no material changes to the previously submitted Explanatory Statement. A 30-day moratorium period applies for any new issue of shares or sale of treasury shares, through 27 December 2025, following the latest repurchase transaction.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1156489206","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156489206","pubTimestamp":1764241373,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"C-MER Medical Holdings Limited (stock code: 03309) announced a Next Day Disclosure Return dated 27 November 2025. According to the filing, the number of issued ordinary shares (excluding treasury...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER医疗(03309)公布购回股份及更新已发行股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER Medical Holdings Limited (stock code: 03309) announced a Next Day Disclosure Return dated 27 November 2025. According to the filing, the number of issued ordinary shares (excluding treasury shares) changed from 1,238,112,870 to 1,237,992,870, while treasury shares increased from 17,448,000 to 17,568,000 on 27 November 2025. The total number of issued shares remained at 1,255,560,870.\nOn 27 November 2025, 120,000 shares were repurchased on the market at prices ranging between HKD 1.72 and HKD 1.74, totaling HKD 207,600. These repurchased shares were designated as treasury shares. The repurchase was conducted under a mandate dated 19 May 2025, authorizing the issuer to repurchase up to 125,556,087 shares, equivalent to 0.0097% of the issued shares as of the mandate date.\nThe filing also disclosed multiple share repurchases for cancellation from 12 July 2024 to 15 May 2025 that have not yet been canceled. The report confirms that the repurchases were in accordance with applicable exchange rules and that there have been no material changes to the previously submitted Explanatory Statement. A 30-day moratorium period applies for any new issue of shares or sale of treasury shares, through 27 December 2025, following the latest repurchase transaction.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156489206","isCrawlerRequest":true}